Risk Factors for Diabetic Ketoacidosis (DKA) for Patients on Sodium/Glucose Cotransporter-2 inhibitor (SGLT2i) Therapy - Poster
Dr Jack Colley, Dr Augustin Brooks
Department of Diabetes and Endocrinology, Royal Bournemouth Hospital
Dr Jack Colley, Dr Augustin Brooks
Department of Diabetes and Endocrinology, Royal Bournemouth Hospital
E Burn1, Giddings J1, Higgins K2, Patel N3
1 Geriatric Medicine Registrar
2 Consultant Diabetologist
3 Consultant Acute Physician
University Hospitals of Leicester NHS Trust
C. Uffendell, S. Dwarampudi, K. Larsen, S. Dwarampudi, S. Miller, L. Wang, C. O'Dowd, U. Srinivas-Shankar
Wirral University Teaching Hospitals NHS Foundation Trust
P Kempegowda1,2, A Kolesnyk3, E Melson1,2, L Thomas3, A Johnson3, D Zhou3, S Ghosh1, P Narendran1,4
1 Department of Diabetes and Endocrinology, Queen Elizabeth Hospital Birmingham, UK
2 Institute of Metabolism and Systems Research, University of Birmingham, Birmingham
3 University of Birmingham Medical School
4 Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK
Following the completion of the terms of office of two of the ABCD officers, we are now seeking nominations and inviting applications from members to stand for election for the following positions.
Lawrence Blonde1, Julio Rosenstock2, Stefano Del Prato3, Robert Henry4, Naim Shehadeh5, Juan Frias6, Elisabeth Niemoeller7, Elisabeth Souhami8, Junlong Wu9, Chen Ji9, Vanita R. Aroda10
This is unique opportunity for someone to join the Specialist Clinic Exam board. Ideally the person will be a generalist, practicing day to day diabetes and endocrinology. However, recognised expertise in any particular field of our speciality will be an advantage. The SCE in diabetes and endocrinology is one of the largest speciality exam held, with several hundred candidates from all over the world sitting each diet, and you would be a part of ensuring the continuing high standard of the exam.
With over 30,000 people admitted to hospital with Covid-19, and up to a third of them with diabetes, we know you are working flat out. With the use of steroids in many patients, the need for glucose monitoring to support care in hospital and support safe discharge is even greater than it was in the first wave. We are really pleased to announce that in response to another request from ABCD-DTN, Abbott’s Diabetes Care division have very kindly agreed to donate 10,000 further FreeStyle Libre 1 sensors to NHS Trusts to support us in this.
There are two main purposes of this donation
Released on 20th January 2021 by London NHS, London COVID-19 dexamethasone and hyperglycaemia: diabetes de-escalation guidance is now available for download.
The statement from PCDS, supported by ABCD and Diabetes UK contains useful updated information to share with community colleagues and patients.